Description
Recombinant monoclonal antibody to Versican. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma N351/23.
Target
Versican
Target Alias Names
N351/23R, Versican core protein, Chondroitin sulfate proteoglycan core protein 2, Chondroitin sulfate proteoglycan 2, Large fibroblast proteoglycan, PG-M
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression